Revati Shreeniwas, MD, prior to entering industry, Dr. Shreeniwas was a practicing physician and served as faculty at Stanford and Columbia University. Dr. Shreeniwas has spent the last two decades as a physician researcher in the pharmaceutical industry. She is passionate about bringing novel therapeutics to patients with an unmet clinical need.
Dr. Shreeniwas has served as an executive level clinical expert with operational knowledge in leading complex programs for a range of therapeutics (Phase I-IV studies). She has worked on several drugs that have gone on to be approved and are commercially successful, including Tracleer Lexiscan, Natrecor, Rytary, Esbriet, Sunosi and Talzenna.
